Rashmi B. Halker Singh

Migraine Care in the Era of COVID‐19: Clinical Pearls and Plea to Insurers

Christina L. Szperka, Jessica Ailani, Rebecca Barmherzig et al. · Headache The Journal of Head and Face Pain · 2020 · 108 citations · Full text

Health Professions, Health Policy, Clinical Medicine +12

Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II

David W. Dodick, Richard B. Lipton, Jessica Ailani et al. · Headache The Journal of Head and Face Pain · 2020 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Patient experience of telemedicine for headache care during the COVID‐19 pandemic: An American Migraine Foundation survey study

Chia‐Chun Chiang, Rashmi B. Halker Singh, Nim Lalvani et al. · Headache The Journal of Head and Face Pain · 2021 · 47 citations · Full text

Public Affairs, Emergency Medical Services, Clinical Medicine +12

Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials

Rashmi B. Halker Singh, Ernesto Aycardi, Marcelo E. Bigal et al. · Cephalalgia · 2018 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine

Erin Doty, John H. Krege, Leah Jin et al. · Cephalalgia · 2019 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15